Rapid Switch From Flolan to Remodulin in the Outpatient ClinicStudy of Intravenous Remodulin in Patients in India With Pulmonary Arterial HypertensionUT-15C SR in the Treatment of Critical Limb IschemiaSafety, Efficacy and Treatment Satisfaction in Patients With PAH Rapidly Switched From Epoprostenol to RemodulinIontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin UlcersSafety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) SubjectsAn Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial HypertensionTrial of the Early Combination of Oral Treprostinil With Background Oral Monotherapy in Subjects With Pulmonary Arterial HypertensionInhaled Treprostinil for PAH: Open-label ExtensionSafety and Efficacy of Inhaled Treprostinil in Patients With PAHImpact of Inhaled Treprostinil Sodium on Ventilation Perfusion MatchingAddition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®Efficacy and Tolerability of Subcutaneously Administered Treprostinil Sodium in Patients With Severe (Non-operable) Chronic Thromboembolic Pulmonary Hypertension (CTREPH)A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil).DelIVery for Pulmonary Arterial Hypertension (PAH)Patient Global Impression Questions for Activity-induced Symptoms in Patients With PAHHemodynamic Evaluation of Dose-response and Safety of Dry Powder Inhalation of TreprostinilInhaled Treprostinil in Sarcoidosis Patients With Pulmonary HypertensionA Safety, Tolerability and Pharmacokinetics Study of TransCon Treprostinil in Healthy Adult Male VolunteersInhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)Observation Study With Implantable Medication Pump for Intravenous Treprostinil Therapy in Patients With Pulmonary Arterial Hypertension
P4844
Q61914607-2C207A69-5A35-4F11-A395-867E6D6C21BDQ61917681-A059DF94-30B9-4371-B9C7-66344351D424Q61924648-D0932A87-D199-4198-811C-D83B5287D5BDQ61932794-7CDA863C-9FB8-4CB1-85B1-7557BCB2FE07Q62025026-E8D6D154-A056-4F42-9231-DA1D1FF69048Q63062656-F176E62E-8B77-4624-9D36-C32E1CAA3DFFQ63316626-24D515B3-F6C8-4848-B4FB-59ABAC12B3DCQ63316631-B7852DA7-7748-4545-8594-C8A6C1895F3AQ63317731-393EDFFE-F001-4C2F-AEA1-6724C633816CQ63317736-963371D1-3FC5-41C7-99BC-78DBBDFFF691Q63319577-552402B8-BCD6-41D0-BC1F-FB4B48C1440CQ63320544-2CFF8407-D8E8-4C8C-8104-F2BB8FD9AE66Q63322847-4D17F477-9BE2-4D57-A0E1-88323D082CDAQ63336439-90117BD3-6ED7-49AE-96A4-2C3ADD4A2006Q63571693-4E9111ED-E1EC-41BB-8A7A-6805C6151FD2Q63581180-18212784-E3D5-4389-B553-86C4ECB40787Q63582161-51FD02C6-A66A-4571-BA3D-2071888C259FQ63582547-C19F8FDF-45C6-42A4-BCE7-4AA4D49AB510Q63585323-38B8F5C0-8FE1-406D-87F6-35969803D42FQ63593406-18545AD6-EBEF-4F06-992D-7D342132EA25Q87932050-D7C99066-C8BD-42B9-B048-D75D2003F320
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Treprostinil
@es
Treprostinil
@id
Treprostinil
@nl
Treprostinil
@sh
Treprostinil
@sr-el
Treprostinil
@vi
treprostinil
@cy
treprostinil
@en
treprostinila
@pt
treprostynil
@pl
type
label
Treprostinil
@es
Treprostinil
@id
Treprostinil
@nl
Treprostinil
@sh
Treprostinil
@sr-el
Treprostinil
@vi
treprostinil
@cy
treprostinil
@en
treprostinila
@pt
treprostynil
@pl
altLabel
(1R,2R,3aS,9aS)-[[2,3,3a,4,9,9 ...... [f]inden-5-yl] oxy]acetic acid
@en
ATC kod B01AC21
@sr
ATCvet kod QB01AC21
@sr
LRX-15
@cy
LRX-15
@en
Orenitram
@cy
Orenitram
@en
Remodulin
@sr
Remodulin®
@cy
Remodulin®
@en
prefLabel
Treprostinil
@es
Treprostinil
@id
Treprostinil
@nl
Treprostinil
@sh
Treprostinil
@sr-el
Treprostinil
@vi
treprostinil
@cy
treprostinil
@en
treprostinila
@pt
treprostynil
@pl
P129
P486
P592
P6366
P646
P661
P662
P665
P683
P129
P2017
CCCCC[C@@H](CC[C@H]1[C@@H](C[C@H]2[C@@H]1CC3=C(C2)C(=CC=C3)OCC(=O)O)O)O
P2067
P2115
N0000148769